What is Oncare?
Oncare operates at the intersection of advanced medical research and patient-centric care. The company provides cutting-edge cancer treatments while simultaneously addressing the psychological burden associated with long-term illness. Unlike traditional corporate health providers, Oncare emphasizes individual treatment plans, ensuring that patients receive tailored care that accounts for both their physical diagnosis and their emotional well-being. This dual-focus model positions the firm as a disruptive force in the oncology sector, challenging the impersonal nature of conventional healthcare delivery.
How much funding has Oncare raised?
Oncare has raised a total of $1M across 1 funding round:
Angel/Seed
$1M
Angel/Seed (2024): $1M with participation from DeVC, Cloud Capital, TRTL Ventures, and HuddleVentures
Key Investors in Oncare
DeVC
A collective of founders, operators, and investors that provides early-stage capital to ambitious entrepreneurs building transformative companies.
HuddleVentures
A venture firm focused on empowering minority entrepreneurs by facilitating access to resources and creating sustainable pathways for wealth creation.
Cloud Capital
Undisclosed investor participating in the funding round.
What's next for Oncare?
With the recent infusion of capital, Oncare is expected to accelerate its research and development initiatives, potentially broadening its clinical trial portfolio and enhancing its digital health infrastructure. The strategic focus will likely shift toward scaling its personalized care model to reach a wider demographic, while simultaneously refining its patient support algorithms. As the company matures, the integration of data-driven insights will be critical in maintaining its competitive advantage. Investors are closely monitoring how this funding will facilitate the transition from a specialized service provider to a broader, more scalable platform capable of setting new standards in patient-focused oncology care.
See full Oncare company page
